Regulatory and Washington

California establishes framework for CBD in supplements, other products
California Gov. Gavin Newsom signed the state’s Assembly Bill 45 into law, establishing a regulatory framework governing the manufacture and sale of products containing CBD.
Industry orgs praise bill allowing supplement purchases with pre-tax money
The Dietary Supplements Act (H.R. 5214) would recognize dietary supplement purchases as qualified medical expenses, allowing them to be purchased using health savings accounts and flexible spending accounts.

Regulatory and Washington
Retail, supplier orgs call for clarity on Biden’s vaccination requirement
In response to President Joe Biden unveiling new vaccination mandates for employers with more than 100 employees, FMI and the Consumer Brand Association are responding.
Generics
FDA marks competitive generic therapy approval milestone
The agency has approved more than 100 generic drugs with the competitive generic therapy designation since it launched the effort in 2017.
Generics
AAM report: Medicare plans lag in adopting new generics
The Association for Accessible Medicines’ latest report found that Medicare Part D plans are slow to add new generics to their formularies and often place them on nongeneric pricing tiers.
Advocacy
NACDS brief supports North Dakota PBM-regulation law
NACDS has filed an amicus brief with the 8th U.S. Circuit Court of Appeals supporting North Dakota's law regulating PBMs and pointing to recent precedent from the Supreme Court to inform the appeals court's ruling.
PHARMACY
NCPA’s Hoey, HHS head Becerra discuss community pharmacy priorities
National Community Pharmacists Association CEO Doug Hoey, in a roundtable discussion with Health and Human Services Secretary Xavier Becerra, focused on four major priorities for independent pharmacies.
Show Watch
Gottlieb offers pandemic overview, praises pharmacy in NACDS Annual remarks
As the keynote speaker of the first Business Program at the virtual 2021 NACDS Annual Meeting, Dr. Scott Gottlieb discussed the industry’s response to the pandemic and sized up what the future holds as vaccinations continue.
Regulatory and Washington
APhA, ASHP back bill expanding Medicare patients’ access to pharmacist services
The Pharmacy and Medically Underserved Area Enhancement Act would give Medicare patients in medically underserved communities access to critically needed primary health care services delivered by pharmacists.
PHARMACY
Legislation on generics, biosimilars headed to Biden's desk
The two pieces of legislation — one focusing on generics, another on biosimilars — are aimed at lowering healthcare costs for consumers.
CBD
FDA warns 2 CBD companies over marketing, manufacturing practices
Honest Globe and Biolyte Labs received letters for their marketing practices, as well as for substandard manufacturing practices, according to the Food and Drug Administration.
Regulatory and Washington
NACDS makes 3 executive moves
The National Association of Chain Drug Stores’ Chris Krese will lead congressional relations and communications, while Christie Boutte and Kathleen Jaeger will assume new policy and advocacy roles.
CBD
CHPA, CRN back bill that would create CBD, hemp framework
The Hemp and Hemp-Derived CBD Consumer Protection and Market Protection Act would direct the Food and Drug Administration to outline a clear federal regulatory framework for hemp and hemp-derived products, promoting consumer safety.
Regulatory and Washington
Retail community welcomes Biden administration’s masking, vaccination efforts
The retail community is making clear that it stands ready to assist recently inaugurated President Joe Biden combat the spread of COVID-19 and get the country vaccinated.